Compare AU
Compare IXJ vs. GARP
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are IXJ and GARP. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.
Community Stats
IXJ | GARP | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 241 | 19 |
Median incremental investment | $1,000.00 | $1,025.10 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,668.00 | $1,626.80 |
Average age group | 26 - 35 | > 35 |
Key Summary
IXJ | GARP | |
|---|---|---|
Strategy | IXJ.AX was created on 2001-11-13 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or smallcapitalisation stocks | GARP.AX was created on 2024-09-24 by Global X. The fund's investment portfolio concentrates primarily on total market equity. The investment objective of the Fund is to provide investors with a return that (before fees and expenses) tracks the performance of the S&P World Ex-Australia GARP.AX Index. |
Top 3 holdings | Eli Lilly and Company (8.25 %) UnitedHealth Group Incorporated (5.81 %) Johnson & Johnson (4.72 %) | Global X S&P World Ex Australia Garp ETF (100 %) |
Top 3 industries | Other (99.98 %) Communication Services (0.02 %) | |
Top 3 countries | United States (99.97 %) | |
Management fee | 0.46 % | 0 % |
Key Summary
IXJ | GARP | |
|---|---|---|
Issuer | iShares | Global X |
Tracking index | S&P Global 1200 Healthcare Sector Index - AUD | S&P World Ex-Australia GARP Index - AUD - Benchmark TR Gross |
Asset class | ETF | ETF |
Management fee | 0.46 % | 0 % |
Price | $139.00 | $11.62 |
Size | $1.414 billion | $7.032 million |
10Y return | 128.07 % | N/A |
Annual distribution/ dividend yield (5Y) | 1.26 % | - % |
Market | ASX | ASX |
First listed date | 11/03/2009 | 25/09/2024 |
Purchase fee | $6.50 | $6.50 |
Community Stats
IXJ | GARP | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 241 | 19 |
Median incremental investment | $1,000.00 | $1,025.10 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,668.00 | $1,626.80 |
Average age group | 26 - 35 | > 35 |
Pros and Cons
IXJ | GARP | |
|---|---|---|
Pros |
|
|
Cons |
|
|
IXJ | GARP |
|---|---|
Higher exposure to US market | Lower exposure to US market |
Higher management fee | Lower management fee |
Higher price growth | Lower price growth |
Higher distribution yield | Lower distribution yield |